Published in Biomaterials on October 01, 1994
Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J (2008) 1.68
Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface (2007) 1.66
In vitro models in biocompatibility assessment for biomedical-grade chitosan derivatives in wound management. Int J Mol Sci (2009) 1.10
Microencapsulating and Banking Living Cells for Cell-Based Medicine. J Healthc Eng (2011) 0.90
Bioactive polymer scaffold for fabrication of vascularized engineering tissue. J Artif Organs (2012) 0.80
Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus. Adv Med (2014) 0.79
Inflammatory response on injection of chitosan/GP to the brain. J Mater Sci Mater Med (2006) 0.78
In vitro cytotoxicity testing of chitosan-containing polyelectrolyte complexes. J Mater Sci Mater Med (1998) 0.77
Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. Cent Eur J Immunol (2014) 0.77
Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. Adv Healthc Mater (2015) 0.77
Constructing a collagen hydrogel for the delivery of stem cell-loaded chitosan microspheres. J Vis Exp (2012) 0.77
Immunoisolation: where regenerative medicine meets solid organ transplantation. Expert Rev Clin Immunol (2012) 0.76
Fabrication and characterization of chitosan microcarrier for hepatocyte culture. J Mater Sci Mater Med (2007) 0.75
Immunoisolation to prevent tissue graft rejection: Current knowledge and future use. Exp Biol Med (Maywood) (2016) 0.75
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci U S A (2002) 2.81
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther (2000) 1.81
A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol (1995) 1.70
Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci (1995) 1.61
Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol (1999) 1.56
Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci (2001) 1.48
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A (2001) 1.47
Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat Biotechnol (2000) 1.42
A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum Gene Ther (1997) 1.42
Treatment of diseases of the central nervous system using encapsulated cells. Adv Tech Stand Neurosurg (1999) 1.39
Syngeneic Schwann cells derived from adult nerves seeded in semipermeable guidance channels enhance peripheral nerve regeneration. J Neurosci (1992) 1.38
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther (2006) 1.38
Tissue reaction to intraperitoneal polymer implants: species difference and effects of corticoid and doxorubicin. J Biomed Mater Res (1989) 1.32
Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol (2001) 1.32
Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. Gene Ther (2009) 1.31
Regrowth of axons into the distal spinal cord through a Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal cord. Eur J Neurosci (1999) 1.30
Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol (2000) 1.29
Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol (1995) 1.26
Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc Natl Acad Sci U S A (2006) 1.23
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease. Neurobiol Dis (2004) 1.22
Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J Neurosci (2000) 1.21
Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci (2001) 1.17
Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther (2002) 1.14
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis (2009) 1.12
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study. Hum Gene Ther (2004) 1.10
The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci (1997) 1.09
Imaging brain amyloid deposition using grating-based differential phase contrast tomography. Neuroimage (2012) 1.08
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther (2003) 1.07
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol Dis (2001) 1.07
Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum Mol Genet (2000) 1.06
Electrically charged polymeric substrates enhance nerve fibre outgrowth in vitro. Biomaterials (1992) 1.05
The functional characteristics of Schwann cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve. J Neurosci (1994) 1.05
Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur J Neurosci (1995) 1.04
Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization. Eur J Neurosci (1997) 1.01
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Hum Gene Ther (2000) 1.01
Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function. Hum Mol Genet (2012) 1.01
GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J Neurosci (1996) 1.01
Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res (1995) 1.01
Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. J Parkinsons Dis (2011) 0.99
Laminin oligopeptide derivatized agarose gels allow three-dimensional neurite extension in vitro. J Neurosci Res (1995) 0.99
Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol (1999) 0.99
Polymer electret guidance channels enhance peripheral nerve regeneration in mice. Brain Res (1989) 0.97
Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol (1993) 0.97
Implication of the JNK pathway in a rat model of Huntington's disease. Exp Neurol (2008) 0.96
Fetal spinal cord tissue in mini-guidance channels promotes longitudinal axonal growth after grafting into hemisected adult rat spinal cords. Neural Plast (1999) 0.96
Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro. J Neurosci Res (1996) 0.94
Application of Teflon-AF thin films for bio-patterning of neural cell adhesion. Biosens Bioelectron (1998) 0.93
Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol (1999) 0.93
In vivo performance of a new biodegradable polyester urethane system used as a nerve guidance channel. Biomaterials (1998) 0.92
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J Comp Neurol (2009) 0.92
Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp Neurol (2001) 0.92
Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum Gene Ther (1996) 0.92
Neuronal cell attachment to fluorinated ethylene propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. II. J Biomed Mater Res (1995) 0.91
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther (2000) 0.91
Three-dimensional extracellular matrix engineering in the nervous system. J Biomed Mater Res (1998) 0.90
Selective neuronal cell attachment to a covalently patterned monoamine on fluorinated ethylene propylene films. J Biomed Mater Res (1993) 0.90
Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology (1996) 0.89
GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci (1997) 0.89
Magnitude and polarity of a fluoroethylene propylene electret substrate charge influences neurite outgrowth in vitro. J Biomed Mater Res (1993) 0.89
Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain (1998) 0.88
Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp Neurol (1998) 0.88
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther (2001) 0.88
Tissue developed around bioresorbable implants. Load-bearing versus histology. ASAIO Trans (1987) 0.88
NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp Neurol (1990) 0.87
Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices. Exp Brain Res (1994) 0.87
SYNDROC: microcomputer based differential diagnosis of malformation patterns. Arch Dis Child (1985) 0.87
Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci (1998) 0.87
Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther (2006) 0.86
Photoimmobilization of a bioactive laminin fragment and pattern-guided selective neuronal cell attachment. Bioconjug Chem (1995) 0.86
Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. Neuroreport (1994) 0.86
Improved nerve regeneration through piezoelectric vinylidenefluoride-trifluoroethylene copolymer guidance channels. Biomaterials (1991) 0.85
Cell therapy using encapsulated cells producing endostatin. Acta Neurochir Suppl (2003) 0.85
Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther (1998) 0.85
Collagen- and laminin-containing gels impede peripheral nerve regeneration through semipermeable nerve guidance channels. Exp Neurol (1987) 0.84
Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci (1993) 0.83
Synthesis and characterization of fluoropolymeric substrata with immobilized minimal peptide sequences for cell adhesion studies. I. J Biomed Mater Res (1995) 0.83
Patterned neuronal attachment and outgrowth on surface modified, electrically charged fluoropolymer substrates. J Biomater Sci Polym Ed (1993) 0.83
Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell Transplant (2001) 0.82
Salivary glands and gene therapy: the mouth waters. Gene Ther (2004) 0.82
Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions. Hum Gene Ther (2004) 0.82
An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp Neurol (1989) 0.82
Transplant of polymer-encapsulated cells genetically engineered to release nerve growth factor allows a normal functional development of the visual cortex in dark-reared rats. Neuroscience (1997) 0.81
Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons. Neuroscience (1998) 0.81
Does renal failure induce a decrease in cyclosporine blood concentrations? Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.80
Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy. Neuroreport (1998) 0.80
Influence of surface texture of polymeric sheets on peripheral nerve regeneration in a two-compartment guidance system. Biomaterials (1991) 0.80
Spatial control of neuronal cell attachment and differentiation on covalently patterned laminin oligopeptide substrates. Int J Dev Neurosci (1994) 0.79
Substance P containing polymer implants protect against striatal excitotoxicity. Brain Res (1993) 0.79
Bovine serum albumin conformation on methyl and amine functionalized surfaces compared by scanning force microscopy. J Biomed Mater Res (1995) 0.79
In vivo calcium deposition on polyvinyl alcohol matrix used in hollow fiber cell macroencapsulation devices. Biomaterials (2004) 0.79
Encapsulated neural transplants. Prog Brain Res (2000) 0.79
Lentiviruses as vectors for CNS diseases. Curr Top Microbiol Immunol (2002) 0.79
The astrocyte inhibition of peripheral nerve regeneration is reversed by Schwann cells. Exp Neurol (1994) 0.79
Encapsulated cells as therapy. Sci Am (1999) 0.79
Mast cells and tissue reaction to intraperitoneally implanted polymer capsules. J Biomed Mater Res (1991) 0.79
Encapsulated thymic epithelial cells as a potential treatment for immunodeficiencies. ASAIO Trans (1989) 0.78
Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced wit lentiviral vectors. J Neurochem (2000) 0.78
Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome. Eur J Neurosci (2001) 0.78
Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy. J Gene Med (2003) 0.78